Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$54.59
+1.05%
Mkt Cap $356.02M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | — | — | -$0.51 | -$0.61 | -19.08% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.46 | -$0.48 | -4.35% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.47 | -$0.35 | +25.53% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.65 | -$0.38 | +41.54% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.36 | -$2.23 | -519.44% | — | — |
| Q4 2024 Nov 8, 2024 | — | — | — | -$0.46 | -$0.37 | +19.57% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.45 | -$0.50 | -11.11% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.85 | -$0.50 | +41.18% | — | — |
| Q1 2024 Mar 28, 2024 | — | — | — | -$0.85 | -$0.60 | +29.41% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.95 | -$0.70 | +26.32% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.95 | -$0.80 | +15.79% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$1.00 | -$0.95 | +5.00% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$1.05 | -$1.10 | -4.76% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$1.15 | -$0.95 | +17.39% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$1.05 | -$1.10 | -4.76% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$1.20 | -$0.95 | +20.83% | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$0.90 | -$1.05 | -16.67% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$1.10 | -$1.00 | +9.09% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$1.05 | -$0.85 | +19.05% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$1.10 | -$0.80 | +27.27% | — | — |